| Revenue growth | 40% QoQ consolidated growth driven by volume recovery. |
|---|---|
| Margins | Sequential improvement; Standalone EBITDA margin 13.4% vs 9.1% in Q3. |
| Demand visibility | Gradual recovery in domestic and global demand noted. |
| Management confidence | Optimistic on long-term outlook despite near-term raw material volatility. |
Growth
Consolidated Q4FY26 revenue grew 40% QoQ to ₹110 Cr; PAT turned positive at ₹1 Cr vs ₹5 Cr loss in Q3.
Outlook
Completed ₹260 Cr Dahej capex; commercial production of GEM Cool 5 and Safranal commenced Feb 2026 for future growth.
Risks
Elevated phenol prices and supply volatility due to geopolitical issues impacting production timelines for phenol derivatives.
Earnings Call filed with BSE, NSE: GEMAROMA. Summary written with AI assistance from the document.
Gem Aromatics Ltd: key numbers
- Share price
- ₹158.93
- Market cap
- ₹830.2 Cr
- Revenue (annual)
- ₹366.5 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- -57.5×Sector 37.5×
- Promoter holding
- 57.45%+0.44% QoQ
- FII holding
- 0.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gem Aromatics Ltd
All →Gem Aromatics Acquisition Worth ₹225.2 Cr
Gem Aromatics Limited is acquiring Krystal Ingredients Private Limited for ₹225.21 Crore through the conversion of a loan into equity.
- Value
- ₹225.2 Cr
Gem Aromatics Acquisition
Gem Aromatics Limited approved converting existing inter-company loans into equity shares of its wholly-owned subsidiary, Krystal Ingredients Private Limited, to strengthen the subsidiary's capital base.
- Execution
- Within one month from receipt of requisite approvals
Gem Aromatics Annual Report
The company submitted a revised Annual Report for FY 2025-26, replacing inadvertently attached unfinalized annexures. No content changes were made to the report.
Gem Aromatics Investor Presentation: Key Takeaways
Gem Aromatics reports Q1FY27 standalone revenue growth of 9% YoY. Strategy focuses on scaling the new Dahej facility and expanding into higher-value specialty molecules like cooling agents and phenol derivatives.
Gem Aromatics Q1 FY27 Results: Net Loss of ₹7.9 Cr
Gem Aromatics Ltd reported revenue from operations of ₹98.8 Cr (+12.8% YoY) and a net loss of ₹7.9 Cr for Q1 FY27.
- Key figure
- Net loss ₹7.9 Cr
Gem Aromatics Earnings Call: Key Takeaways
Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.